UnitedHealthcare · Cgm Dexcom · US health-plan appeal rights

Cgm Dexcom denied due to quantity / dose limits by UnitedHealthcare?

Q: How long do I have to appeal a UnitedHealthcare Cgm Dexcom denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-11

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What UnitedHealthcare typically requires

UnitedHealthcare's specific coverage criteria for cgm dexcom are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: UHC Continuous Glucose Monitoring and Insulin Delivery for Managing Diabetes

The UnitedHealthcare angle on Cgm Dexcom

## Why UnitedHealthcare Denied Your Dexcom CGM — Quantity Limits

UnitedHealthcare's coverage policy for continuous glucose monitors includes quantity limits — restrictions on how many sensors, receivers, or transmitters it will cover within a given supply period. When your prescription or refill exceeds those limits, the claim is denied. This may happen at initial fill, at renewal, or when a clinician prescribes a higher-frequency sensor replacement than the default limit allows. The denial is appealable, particularly when your prescriber can document why a higher quantity is medically necessary for your specific clinical situation.

## Why This Denial Is Appealable

Quantity limits are set based on typical use patterns, but individual patients can have legitimate medical reasons to require a higher quantity — such as accelerated sensor failures due to a specific skin condition, higher activity levels affecting adhesion, or more frequent calibration requirements documented by the prescriber. An appeal gives your physician the opportunity to explain why the standard quantity is insufficient for your care.

## Federal Appeal Framework

Internal appeal: You have the right under ACA §2719 and ERISA §503 to challenge this determination. Submit your appeal within the timeframe on your denial notice.
External review: If the internal appeal fails, you may escalate to independent external review, typically within approximately four months of the final internal denial. An IRO will evaluate whether UHC's application of the quantity limit was clinically appropriate given your circumstances.
Expedited review: If running out of supplies poses an immediate health risk (e.g., inability to detect hypoglycemia), request expedited processing.

## Documentation to Gather

1. Prescriber letter with quantity justification — your doctor should explain in writing why the prescribed quantity is medically necessary, citing your specific clinical circumstances (sensor failure rate, activity level, any documented sensor-related issues). 2. UHC quantity limit policy — obtain the exact published limit and the exception criteria from UHC's coverage policy or prior-auth guidelines. Your appeal must show your situation qualifies for an exception. 3. Diagnosis and clinical context — chart notes documenting your diabetes management regimen, glycemic variability, and any complications that increase monitoring needs. 4. Usage log or dispensing history — pharmacy or device records showing actual usage and any documented sensor failures or replacements. 5. Sensor failure documentation — if sensors are failing more often than expected, any device trouble-ticket records from Dexcom support can substantiate this.

## Criteria-Mapping Structure

| Quantity Exception Criterion (per UHC policy) | Supporting Evidence | |---|---| | Medical reason quantity limit is insufficient | [Prescriber letter, date] | | Clinical circumstance driving higher need | [Chart notes, failure logs, dates] | | Prescriber has reviewed and confirms need | [Letter signature, date, NPI] |

Present the criteria-mapping table alongside the prescriber's letter so the reviewer can follow the reasoning directly.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other UnitedHealthcare appeals

Other insurers on Cgm Dexcom

Other denial reasons for UnitedHealthcare Cgm Dexcom

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-11. Editorial standards: denialhelp.com/authors.